Analysts raise Lumentum’s price target to $1,000 after fiscal Q4 results exceed expectations, driving a 7% stock gain.
Lumentum (LITE) shares climbed 7% following fiscal fourth-quarter results that prompted positive analyst reactions. The company’s performance and outlook led Morgan Stanley to lift its price target to $1,000 from $900 while maintaining an Equal-weight rating on the stock.
Prior to the report, expectations were mixed, with some analysts awaiting signs of sustained growth. The $100 increase in the price target reflects confidence in Lumentum’s near-term prospects, though the Equal-weight stance suggests a balanced view on valuation.
The stock’s rise reflects investor optimism about the company’s trajectory, though broader market conditions may influence further movement.